The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

@article{Kurman2010TheOA,
  title={The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory},
  author={Robert J. Kurman and Ie-Ming Shih},
  journal={The American Journal of Surgical Pathology},
  year={2010},
  volume={34},
  pages={433-443}
}
  • R. Kurman, I. Shih
  • Published 2010
  • Biology, Medicine
  • The American Journal of Surgical Pathology
Ovarian cancer is the most lethal gynecologic malignancy. Efforts at early detection and new therapeutic approaches to reduce mortality have been largely unsuccessful, because the origin and pathogenesis of epithelial ovarian cancer are poorly understood. Despite numerous studies that have carefully scrutinized the ovaries for precursor lesions, none have been found. This has led to the proposal that ovarian cancer develops de novo. Studies have shown that epithelial ovarian cancer is not a… Expand
Origin and molecular pathogenesis of ovarian high-grade serous carcinoma.
  • R. Kurman
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2013
TLDR
The dualistic model serves as a framework for studying ovarian cancer and can assist investigators in organizing this complex group of neoplasms and facilitates the development of new and novel approaches to prevention, screening and treatment of this devastating disease. Expand
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.
TLDR
It now appears that type I and type II ovarian tumors develop independently along different molecular pathways and that both types develop outside the ovary and involve it secondarily, leading to the conclusion that the only true primary ovarian neoplasms are gonadal stromal and germ cell tumors analogous to testicular tumors. Expand
New insights into ovarian cancer pathology.
  • J. Prat
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2012
TLDR
Recent advances in the molecular pathology which have greatly improved the understanding of the biology of ovarian carcinoma are summarized and are also relevant to patient management. Expand
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
  • J. Prat
  • Biology, Medicine
  • Virchows Archiv
  • 2012
TLDR
Recent advances in the molecular pathology which have greatly improved the understanding of the biology of ovarian carcinoma are summarized and are also relevant to patient management. Expand
Contemporary Treatment Strategies for Rare Epithelial Ovarian Cancers
TLDR
A review of the rare epithelial ovarian cancer subtypes, including current best clinical practices for the management of each tumor type is presented, including a "one-size-fits-all" treatment approach. Expand
The Duplicitous Origin of Ovarian Cancer
TLDR
The need to shift the paradigm away from the classification of ovarian cancer as a single disease with a single cellular origin is proposed, which will facilitate devising new methods for fighting this cancer and improving the life of many women inflicted with the disease. Expand
The evolving pathogenesis model of high-grade pelvic serous carcinoma.
TLDR
The data to suggest that the ovarian cortical inclusion cyst is a site of origin for some HGPSCs represent the union of these concepts, with FTSEC being shed onto the ovarian surface and subsequently undergoing invagination into a cortical inclusion Cyst, which serves as a site for malignant transformation. Expand
The origin of ovarian cancers--hypotheses and controversies.
TLDR
This hypothesis would account for OSE and fimbriae giving rise to identical carcinomas, and for their susceptibility to neoplastic transformation that is absent in the adjacent extraovarian serosa and oviductal ampulla. Expand
Precursors and pathogenesis of ovarian carcinoma
TLDR
Recent developments in the pathogenesis of ovarian carcinoma are discussed, with particular emphasis on the putative precursor lesions that give rise to the major histological subtypes. Expand
Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.
TLDR
A new paradigm for the pathogenesis of female pelvic cancer helps explain persistent problems in describing the development and diverse morphology of these neoplasms and facilitates the development of novel approaches to prevention, screening, and treatment of this devastating disease. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 47 REFERENCES
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.
TLDR
This model of carcinogenesis reconciles the relationship of borderline tumors to invasive carcinoma and provides a morphological and molecular framework for studies aimed at elucidating the pathogenesis of ovarian cancer. Expand
The cell of origin of ovarian epithelial tumours.
  • L. Dubeau
  • Biology, Medicine
  • The Lancet. Oncology
  • 2008
TLDR
Recent epidemiological and molecular biological findings as well as evidence based on histopathological observations of surgical specimens from individuals with familial ovarian cancer predisposition are discussed, including evidence that primary ovarian epithelial tumours, fallopian tube carcinomas, and primary peritoneal carcinomas are Müllerian in nature. Expand
The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma: A Morphologic and Molecular Genetic Analysis
TLDR
The clonality of 6 cases of high-grade serous carcinomas that were closely associated with atypical proliferative serous (borderline) tumors and invasive low-grade micropapillary serous cancers was determined. Expand
Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases
TLDR
Subdividing ovarian CCCs into cystic and adenofibromatous CCC reveals differences in a number of clinicopathologic features including their association with endometriosis, histologic patterns, stage distribution, and clinical behavior. Expand
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
TLDR
It is suggested that the use of PIK3CA-targeting drugs may offer a more effective therapeutic approach compared with current chemotherapeutic agents for patients with advanced-stage and recurrent CCC. Expand
Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.
The clinicopathologic features of uterine serous carcinoma (USC) lacking myometrial invasion, including its putative precursor lesion endometrial intraepithelial carcinoma (EIC), have not beenExpand
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
TLDR
The Fallopian tubes of women predisposed to developing ovarian cancer frequently harbour dysplastic changes, accompanied by changes in cell‐cycle and apoptosis‐related proteins, indicating an increased risk of developing tubal cancer. Expand
Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers
TLDR
A large, blinded review of tubes from BRCA mutation carriers confirms previous reports of putative cancer precursors in distal tubal mucosa, and that p53 signatures occur with similar frequency in women at low and high genetic risk of tubal/ovarian carcinoma. Expand
Ovarian Cancer
  • I. Judson
  • Medicine
  • British Journal of Cancer
  • 1993
TLDR
It is thought that the development of animal models in which ovarian cancer can be induced and studied during its early stages will enable better understanding of early ovarian cancer lesions and elucidate molecular events that support ovarian cancer progression. Expand
Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification
  • E. Jarboe, A. Folkins, +5 authors C. Crum
  • Biology, Medicine
  • International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
  • 2008
TLDR
A continuum of epithelial change validates the SCAT sequence and the fimbrial secretory cell as the site of origin for many serous carcinomas. Expand
...
1
2
3
4
5
...